May 18,2021 MD Anderson and Refuge Biotechnologies Collaborate to Advance Next-Generation Cell Therapies for Treatment of Solid Tumors read more >>
Apr 28,2021 Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer read more >>
Mar 30,2021 Immune-Onc Therapeutics Announces $73 Million in Series B1 and B2 Financing to Advance its Portfolio of Novel Immunotherapies in Blood Cancers and Solid Tumors read more >>
Mar 17,2021 Alveo Technologies' be.well COVID-19 Test Wins XPRIZE Rapid Covid Testing Competition read more >>
Mar 16,2021 Twist Bioscience Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021 read more >>
Feb 05,2021 CULLGEN CLOSES $50 MILLION SERIES B INVESTMENT TO ADVANCE TARGETED PROTEIN DEGRADERS AND NOVEL E3 LIGANDS PLATFORM read more >>
Jan 06,2021 C4 Therapeutics Announces Key 2021 Milestones to Support Progress Toward Goal of Four Clinical-Stage Programs by Year-End 2022 read more >>